scholarly article | Q13442814 |
P50 | author | Hiroyasu Nakano | Q55277402 |
Hiroaki Sakurai | Q37371428 | ||
P2093 | author name string | Shunsuke Suzuki | |
Ikuo Saiki | |||
Takahiro Doi | |||
Pattama Singhirunnusorn | |||
P2860 | cites work | Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses | Q44298024 |
A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts | Q44482174 | ||
Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo | Q47070611 | ||
Detection of glia-derived nexin in the olfactory system of the rat. | Q55486235 | ||
Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells | Q72615239 | ||
Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors | Q77402137 | ||
Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway | Q24306909 | ||
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation | Q24321727 | ||
A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB | Q24321775 | ||
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity | Q27860643 | ||
The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation | Q28252726 | ||
NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses | Q28505819 | ||
Signaling to NF-kappaB | Q29547844 | ||
Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation | Q29617419 | ||
NF-kappaB: a key role in inflammatory diseases | Q29617726 | ||
Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif | Q30762839 | ||
Series introduction: the transcription factor NF-kappaB and human disease | Q34116362 | ||
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Q34131747 | ||
Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway | Q34214145 | ||
NF-kappaB signaling pathways in mammalian and insect innate immunity | Q34373155 | ||
Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice | Q34832169 | ||
Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter | Q35772792 | ||
Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis | Q36114916 | ||
Plasminogen activator inhibitor type 2 in breast cancer. | Q36430997 | ||
Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA. | Q38348585 | ||
Characterization of the human protease nexin-1 promoter and its regulation by Sp1 through a G/C-rich activation domain. | Q38354683 | ||
Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. | Q38480250 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | NF-κB | Q411114 |
TNF | Q18032037 | ||
P304 | page(s) | 3257-3262 | |
P577 | publication date | 2006-05-06 | |
P1433 | published in | FEBS Letters | Q1388051 |
P1476 | title | Identification of TNF-alpha-responsive NF-kappaB p65-binding element in the distal promoter of the mouse serine protease inhibitor SerpinE2. | |
P478 | volume | 580 |